SARS-CoV-2 Vaccination Not Associated With a First Episode of Thrombotic Thrombocytopenia Purpura
A large, multicenter, retrospective study also showed that SARS-CoV-2 vaccination does not trigger relapse in patients with TTP, particularly if patients are monitored regularly and do not have low ADAMTS13 enzyme activity.
Advancing Hematology Practices in Arequipa, Peru
For the past two years, the global hematology/oncology community has been forced to adapt to the challenges of working and treating patients during the COVID-19 pandemic. For the hematologists in Arequipa, Peru, these challenges have been particularly great.
Aaron Gerds, MD
Deputy Director for Clinical Research, Cleveland Clinic Taussig Cancer Institute
Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
In the Marvel blockbuster Doctor Strange, the Ancient One advises, “Measure your next words very carefully, Doctor.” This is sage advice for us all. While non-verbal cues are a big part of communication, the words we select when communicating are of the utmost importance.
Most Read Articles
- Phase III POLARIX Study Shows Greater Progression-Free Survival With Pola-R-CHP Versus R-CHOP in Previously Untreated DLBCL
- Finding Joy and Purpose Through Lifelong Learning
- Filling the Gap: Hematology Fellowships Prepare APs for Specialized Career Paths
- Dara-KRd With MRD Response-Adapted Therapy Leads to High MRD Negativity for Newly Diagnosed MM
- Adding Durvalumab to Chemotherapy Does Not Improve Outcomes in MDS
Watch now for thoughts on the June 2022 issue of ASH Clinical News from Editor-in-Chief Aaron Gerds, MD.
Researchers have trained ants to sniff out cancer cells, demonstrating that they can be trained more quickly than dogs, and for less money, too.
In this edition, Eleni Gavriilaki, MD, PhD, reflects on her lifelong relationship with music and how she views playing the violoncello (aka the cello) as a mind-body experience.